NEWS

 

Title Date
Oneness Biotech invited for oral presentation at the 36th Healthcare Conference organized by J.P. Morgan 2017-12-27
Oneness Biotech filed the second Phase 3 IND of ON101 to FDA. 2017-11-21
Oneness Biotech has licensed out ON101, a novel drug for treating diabetic foot ulcer to Microbio Shanghai for co-development and commercialization in mainland China, Hong Kong and Macao. 2017-11-10
Oneness Biotech has licensed out OB318, a novel drug candidate for hepatocellular carcinoma to Microbio Shanghai for co-development and commercialization in mainland China, Hong Kong and Macao. 2017-11-10
The multinational phase III clinical trial of ON101 has been greenlighted by CFDA 2017-07-18